Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Burkitt Lymphoma 27Neoplasm, Residual 13Leukemia 6Recurrence 5Leukemia, Biphenotypic, Acute 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphoid 3Myelodysplastic Syndromes 2Lymphoma, B-Cell 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Hematologic Neoplasms 2Blast Crisis 2Sarcoma, Myeloid 1Philadelphia-Negative ALL 1Philadelphia Chromosome 1Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid 1Leukemia, Large Granular Lymphocytic 1Leukemia, B-Cell 1Hodgkin Disease 1Graft vs Host Disease 1

Interventions

Cyclophosphamide 54Tacrolimus 50Methotrexate 36Mycophenolic Acid 34fludarabine phosphate 33Busulfan 31Cyclosporine 29fludarabine 28Antilymphocyte Serum 28Melphalan 23Sirolimus 21Whole-Body Irradiation 18Radiotherapy 18Peripheral Blood Stem Cell Transplantation 18Methylprednisolone 18Filgrastim 15thymoglobulin 13Thiotepa 10Stem Cell Transplantation 9Rituximab 9Granulocyte Colony-Stimulating Factor 8Hematopoietic Stem Cell Transplantation 7Etoposide 7Cord Blood Stem Cell Transplantation 7Cytarabine 6Alemtuzumab 6ruxolitinib 5Transplantation 5Therapeutics 5Prednisone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Graft vs Host Disease × blinatumomab × Clear all
NCT07297914 2025-12-22

FORUM2

Bambino Gesù Hospital and Research Institute

Phase 2/3 Not yet recruiting
1,000 enrolled
LymphoidOther hematologic neoplasm

Graft vs Host Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡